- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
APOBEC3G AntibodyPeptide-affinity purified goat antibody
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AF1080a | 0.1mg 400 ul | 7-10 days | $ 325.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
APOBEC3G Antibody - Product info | |
| Other Accession | NP_068594 |
| Reactivity | Human |
| Concentration | 100ug/200ul |
| Isotype | IgG |
APOBEC3G Antibody - Additional info | |
| Other Names APOBEC3G; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G; ARP9; CEM15; FLJ12740; MDS019; bK150C2.7; dJ494G10.1 ; DNA dC->dU editing enzyme; OTTHUMP00000028911; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G; phorbolin-like protein MDS019 | |
| Format 0.5 mg IgG/ml in Tris saline (20mM Tris pH7.3, 150mM NaCl), 0.02% sodium azide, with 0.5% bovine serum albumin | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions APOBEC3G Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
APOBEC3G Antibody - Application data
-
AF1080a (0.5 µg/ml) staining of Daudi lysate (35 µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
APOBEC3G Antibody - Related products
AP1351a: CEM15 Antibody (N-term)
AP1351b: APOBEC3G (CEM15) Antibody (Center E133)
AP1351c: APOBEC3G (CEM15) Antibody (Center D143)
AP1351d: APOBEC3G (CEM15) Antibody (C-term)
RI10341: APOBEC3G predesign siRNA
LY11888a: APOBEC3G Over-expression Lysate
BP1351a: CEM15 Antibody (N-term) Blocking Peptide
BP1351b: CEM15 Antibody (Center E133) Blocking Peptide
BP1351c: CEM15 Antibody (Center D143) Blocking Peptide
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. The protein encoded by this gene has been found to be a specific inhibitor of human immunodeficiency virus-1 (HIV-1) infectivity.
REFERENCES
A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Zhou Y, et al. Immunology, 2010 Sep. PMID 20636339. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity. Dang Y, et al. J Virol, 2010 Sep. PMID 20592083. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. Vartanian JP, et al. PLoS Pathog, 2010 May 27. PMID 20523896. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. Sadler HA, et al. J Virol, 2010 Jul. PMID 20463080. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. Fan J, et al. J Virol, 2010 Jul. PMID 20463074.